Cytovia Therapeutics Presents New Data on TALEN® Gene-Edited iNK Cells and GPC3-Targeted Flex-NK™ Bispecific Antibodies at 2022 SITC Annual Meeting
Cytovia Therapeutics Presents New Data on TALEN® Gene-Edited iNK Cells and GPC3-Targeted Flex-NK™ Bispecific Antibodies at 2022 SITC Annual Meeting - read this article along with other careers information, tips and advice on BioSpace
United States New York Israel General Daniel Teper York Stem Cell Foundation National Cancer Institute
Source: biospace.com